(Q37278993)

English

Genetic epidemiology of bladder cancer: scaling up in the identification of low-penetrance genetic markers of bladder cancer risk and progression

scientific article published on September 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

19 August 2017

1 reference

Europe PubMed Central

Genetic epidemiology of bladder cancer: scaling up in the identification of low-penetrance genetic markers of bladder cancer risk and progression (English)

1 reference

Europe PubMed Central

19 August 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Núria Malats

1

1 reference

Europe PubMed Central

19 August 2017

publication date

1 September 2008

1 reference

Europe PubMed Central

19 August 2017

Scandinavian Journal of Urology and Nephrology. Supplement

1 reference

Europe PubMed Central

19 August 2017

131-140

1 reference

Europe PubMed Central

19 August 2017

218

1 reference

Europe PubMed Central

19 August 2017

Screening for bladder cancer: a perspective

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

Risk of bladder cancer associated with family history of cancer: do low-penetrance polymorphisms account for the increase in risk?

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

Familial aggregation of urothelial cell carcinoma

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

Genetic polymorphism in bladder cancer.

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

N-acetyltransferase 2 and bladder cancer: an overview and consideration of the evidence for gene-environment interaction

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

Genetic polymorphisms of N-acetyltransferase 1 and 2 and risk of cigarette smoking-related bladder cancer

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

GST, NAT, SULT1A1, CYP1B1 genetic polymorphisms, interactions with environmental exposures and bladder cancer risk in a high-risk population

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

Joint effects of the N-acetyltransferase 1 and 2 (NAT1 and NAT2) genes and smoking on bladder carcinogenesis: a literature-based systematic HuGE review and evidence synthesis

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

Glutathione S-transferase mu1 (GSTM1) status and bladder cancer risk: a meta-analysis

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

Pooled analysis and meta-analysis of glutathione S-transferase M1 and bladder cancer: a HuGE review

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

Susceptibility genes: GSTM1 and GSTM3 as genetic risk factors in bladder cancer.

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

Polymorphisms of glutathione S-transferase genes (GSTM1, GSTP1 and GSTT1) and bladder cancer susceptibility in the Turkish population

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

GSTP1 A1578G (Ile105Val) polymorphism in benzidine-exposed workers: an association with cytological grading of exfoliated urothelial cells

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

GSTT1-null genotype is a protective factor against bladder cancer

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

Combined effect of glutathione S-transferase M1 and T1 genotypes on bladder cancer risk

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

Pooled analysis and meta-analysis of the glutathione S-transferase P1 Ile 105Val polymorphism and bladder cancer: a HuGE-GSEC review

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

Sulfotransferase 1A1 (SULT1A1) polymorphism and bladder cancer risk: a case-control study.

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

An association of UDP-glucuronosyltransferase 2B7 C802T (His268Tyr) polymorphism with bladder cancer in benzidine-exposed workers in China

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

Genetic polymorphisms of MPO, COMT, MnSOD, NQO1, interactions with environmental exposures and bladder cancer risk

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

Increased risk of bladder cancer associated with a glutathione peroxidase 1 codon 198 variant

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

No association between SOD2 or NQO1 genotypes and risk of bladder cancer

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

Genetic polymorphism of GSTM1, CYP2E1 and CYP2D6 in Egyptian bladder cancer patients

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

Impact of CYP2E1 genotype in renal cell and urothelial cancer patients.

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

An association between NQO1 genetic polymorphism and risk of bladder cancer

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

CYP1A2 activity as a risk factor for bladder cancer

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

CYP2E1 and NQO1 genotypes, smoking and bladder cancer

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

Permanent hair dyes and bladder cancer: risk modification by cytochrome P4501A2 and N-acetyltransferases 1 and 2.

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

Frequencies of poor metabolizers of cytochrome P450 2C19 in esophagus cancer, stomach cancer, lung cancer and bladder cancer in Chinese population

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

Polymorphisms in DNA repair and metabolic genes in bladder cancer

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

Polymorphisms/haplotypes in DNA repair genes and smoking: a bladder cancer case-control study.

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

Bladder cancer predisposition: a multigenic approach to DNA-repair and cell-cycle-control genes.

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

Evaluation of genetic variation in the double-strand break repair pathway and bladder cancer risk.

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

p53 codon 72 polymorphism and its association with bladder cancer

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

p21 gene codon 31 polymorphism is associated with bladder cancer

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

A case-control study of cyclin D1 CCND1 870A-->G polymorphism and bladder cancer.

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

Predictive value of expression of transforming growth factor-beta(1) and its receptors in transitional cell carcinoma of the urinary bladder

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

An intronic variant of the TGFBR1 gene is associated with carcinomas of the kidney and bladder

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

Polymorphisms of folate metabolic genes and susceptibility to bladder cancer: a case-control study

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

Lack of evidence for the association of tumor necrosis factor-alpha gene promoter polymorphism with calcium oxalate stone and bladder cancer patients

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

Interleukin-4 gene intron-3 polymorphism is associated with transitional cell carcinoma of the urinary bladder.

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

Polymorphism in the nuclear factor kappa-B binding promoter region of cyclooxygenase-2 is associated with an increased risk of bladder cancer.

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

Profiling of genetic variations in inflammation pathway genes in relation to bladder cancer predisposition.

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

Role of N-acetyltransferase phenotypes in bladder carcinogenesis: a pharmacogenetic epidemiological approach to bladder cancer

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

Glutathione S-transferase M1 gene polymorphism in bladder cancer patients. a marker for invasive bladder cancer?

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

Cyclin D1 gene polymorphism is associated with an increased risk of urinary bladder cancer.

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

Association between glutathione S-transferase M1 and T1 polymorphisms and increased risk for bladder cancer in Korean smokers

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

Polymorphisms in tumour necrosis factor (TNF) are associated with risk of bladder cancer and grade of tumour at presentation

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

Association Between A C/A Single Nucleotide Polymorphism of the E-Cadherin Gene Promoter and Transitional Cell Carcinoma of the Bladder

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

HRAS1 variable number of tandem repeats polymorphism and risk of bladder cancer.

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

Polymorphism within the cyclin D1 gene is associated with an increased risk of carcinoma in situ in patients with superficial bladder cancer

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

Nucleotide excision repair gene polymorphisms and recurrence after treatment for superficial bladder cancer.

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

Influence of GSTM1, GSTT1, GSTP1 and NAT2 genotypes on the p53 mutational spectrum in bladder tumours

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

Genetic polymorphisms of CYP2D6, GSTM1, and GSTT1 genes and bladder cancer risk in North India

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

Genotypes of TNF-alpha, VEGF, hOGG1, GSTM1, and GSTT1: useful determinants for clinical outcome of bladder cancer

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

A polymorphism in HDM2 (SNP309) associates with early onset in superficial tumors, TP53 mutations, and poor outcome in invasive bladder cancer

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

Cytochrome P450 (CYP) 1A2, sulfotransferase (SULT) 1A1, and N-acetyltransferase (NAT) 2 polymorphisms and susceptibility to urothelial cancer.

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

Immunohistochemical analysis of NAD(P)H:quinone oxidoreductase and NADPH cytochrome P450 reductase in human superficial bladder tumours: relationship between tumour enzymology and clinical outcome following intravesical mitomycin C therapy.

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

Single nucleotide polymorphisms in DNA repair genes might be prognostic factors in muscle-invasive bladder cancer patients treated with chemoradiotherapy

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

Challenges and complexities in estimating both the functional impact and the disease risk associated with the extensive genetic variation in human DNA repair genes

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

High-order interactions among genetic polymorphisms in nucleotide excision repair pathway genes and smoking in modulating bladder cancer risk.

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

DNA repair polymorphisms modify bladder cancer risk: a multi-factor analytic strategy

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

Large-scale evaluation of candidate genes identifies associations between VEGF polymorphisms and bladder cancer risk

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

The road to genome-wide association studies

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

Familial Transitional Cell Carcinoma

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

Genetic Variation in the Nucleotide Excision Repair Pathway and Bladder Cancer Risk

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

Genetic variation in the base excision repair pathway and bladder cancer risk

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

Polymorphisms in one-carbon metabolism and trans-sulfuration pathway genes and susceptibility to bladder cancer

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

Clinical course of bladder neoplasms and single nucleotide polymorphisms in theCDKN2Agene

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

When the smoke clears ..

1 reference

https://api.crossref.org/works/10.1080%2F03008880802285172

21 January 2018

Identifiers

10.1080/03008880802285172

1 reference

Europe PubMed Central

19 August 2017

1 reference

Europe PubMed Central

19 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37278993&oldid=1699165273"